Orthostatic Cerebral Hypoperfusion Syndrome (OCHOS)
Orthostatic intolerance means symptoms that occur or worsen in the upright position. The diagnostic framework for identifying it has been built around two measurable thresholds: does heart rate increase by 30 beats per minute (POTS), and does blood pressure fall by 20 mmHg (orthostatic hypotension)? A patient whose tilt test crosses one of those thresholds gets a diagnosis. A patient whose tilt test crosses neither is told their orthostatic physiology is normal. Dr. Peter Novak's 2016 paper in Frontiers in Aging Neuroscience identifies the problem with this framework and proposes a specific diagnostic category to address it: Orthostatic Cerebral Hypoperfusion Syndrome, or OCHOS. OCHOS is defined by a measurable fall in cerebral blood flow velocity during tilt that cannot be explained by blood pressure, heart rate, arrhythmia, or structural cardiac disease. The peripheral numbers are fine. The brain is not receiving adequate blood flow. The standard framework has no mechanism for detecting this, and the OCHOS category is an attempt to name the gap so it can be addressed.
Defining OCHOS: What the Diagnosis Captures
The formal definition of OCHOS in the Novak 2016 paper is specific: a fall in cerebral blood flow velocity during orthostatic challenge, measured by transcranial Doppler of the middle cerebral artery, that is not attributable to the cardiovascular mechanisms standard tilt testing is designed to detect. The blood pressure does not fall to orthostatic hypotension criteria. The heart rate does not rise to POTS criteria. There is no arrhythmia. There is no structural cardiac explanation. The systemic cardiovascular response to upright posture is, by every standard metric, within normal limits.
What is not within normal limits is the cerebral perfusion. The brain's blood supply falls when the patient is tilted. The fall is reproducible — it occurs consistently during orthostatic challenge. It correlates with symptoms — the patient feels worse when upright, and the magnitude of the cerebral blood flow fall during tilt corresponds to the severity of that symptom experience. The condition is real, measurable, and physiologically coherent. It is simply invisible to an evaluation that does not measure cerebral blood flow.
The Mechanism: Why Systemic Vitals Can Be Normal While the Brain Fails
The mechanism behind OCHOS involves the cerebrovascular system's failure to maintain adequate perfusion during gravitational stress through a pathway that bypasses the cardiovascular responses standard testing monitors. Three related mechanisms are implicated.
The first is impaired cerebrovascular autoregulation. The brain normally maintains stable cerebral blood flow across a range of systemic blood pressures through autoregulatory mechanisms — cerebral arterioles dilate when blood pressure falls and constrict when it rises, buffering the brain against systemic hemodynamic fluctuations. When autoregulation is impaired, this buffering fails. Cerebral blood flow tracks more passively with systemic pressure, and the normal pressure reduction associated with upright posture — modest enough that it doesn't cross orthostatic hypotension criteria — is no longer buffered at the cerebrovascular level. The brain experiences the full hemodynamic impact of an orthostatic challenge that the standard evaluation would not classify as abnormal.
The second is CO₂ dysregulation. CO₂ is the primary chemical regulator of cerebral arteriolar tone, and a 10 mmHg reduction in CO₂ can reduce cerebral blood flow by 20 to 30 percent through direct vasoconstriction. Postural hyperventilation — increased breathing rate that occurs specifically with upright posture in susceptible patients — drives CO₂ reduction. In a patient with OCHOS, CO₂-driven vasoconstriction may be contributing to or causing the cerebral blood flow fall entirely independently of systemic hemodynamics.
The third is abnormal cerebrovascular reactivity — an altered sensitivity of the cerebrovascular system to the stimuli that normally regulate it. The vessels may vasoconstrict more aggressively in response to CO₂ changes, or dilate less effectively in response to reduced perfusion pressure, or both. The net effect is a cerebrovascular system that cannot adequately defend the brain's blood supply against the combined hemodynamic and chemical challenges of upright posture.
How OCHOS Differs from POTS, HYCH, and Orthostatic Hypotension
The orthostatic intolerance syndrome landscape includes several overlapping but distinct conditions, each representing a different point of failure in the cardiovascular-cerebrovascular response to upright posture. OCHOS occupies a specific position in this landscape that Novak's paper makes explicit.
POTS involves orthostatic cerebral hypoperfusion driven primarily by hemodynamic failure — inadequate venous return, falling cardiac output, and compensatory tachycardia that crosses the 30 bpm threshold. The tachycardia is what gets detected. HYCH, defined by Novak in a 2018 paper, involves the same cerebral hypoperfusion through CO₂-driven vasoconstriction without sufficient tachycardia to cross the POTS threshold. Both are detectable only with transcranial Doppler and capnography. Orthostatic hypotension involves peripheral blood pressure falling to a defined threshold, which may or may not correspond to cerebral hypoperfusion depending on whether cerebrovascular autoregulation compensates effectively.
OCHOS differs from all of these in that the peripheral hemodynamic response is entirely within normal limits. There is no POTS tachycardia. There is no hypotension. The distinguishing feature of OCHOS is that the failure occurs entirely at the level of the cerebrovascular system — in autoregulation, CO₂ responsiveness, or both — without the cardiovascular compensation failures that produce the markers standard testing detects. This is not a less severe condition than POTS or HYCH. It may be the same severity at the level of cerebral perfusion with different peripheral physiology masking the problem.
Why Standard Tilt Testing Cannot Identify OCHOS
The invisibility of OCHOS to standard testing is not a failure of clinical technique. It is a structural consequence of what standard testing measures. Tilt table testing with heart rate and blood pressure monitoring is designed to detect specific cardiovascular compensation failures: the tachycardia of POTS, the pressure drop of orthostatic hypotension. It does not measure cerebral blood flow, cerebrovascular reactivity, or CO₂. A patient with OCHOS presents with none of the cardiovascular abnormalities the test is designed to detect. The test produces a normal result because the thing it is measuring — cardiovascular compensatory responses — is normal. The thing it is not measuring — cerebrovascular function — is not normal.
A patient with OCHOS will pass a standard tilt test. Reliably. Repeatedly. Every evaluation using standard metrics will produce a normal result. The clinical conclusion drawn from those normal results — that the patient's orthostatic physiology is normal and their symptoms require explanation elsewhere — follows logically from the data. The data, however, were collected with tools that cannot see the problem. Van Campen and colleagues documented exactly this pattern in ME/CFS patients: normal heart rate and blood pressure during tilt coexisting with 22 to 30 percent cerebral blood flow reductions. OCHOS is the named diagnostic category that describes that pattern when it cannot be attributed to blood pressure or heart rate changes.
OCHOS as a Framework for Advocacy and Evaluation
The practical value of the OCHOS designation, as Novak emphasizes, is that naming makes a condition visible in clinical communication. A patient who can say "I believe I may have OCHOS and would like cerebral blood flow velocity measured during tilt" is making a specific, clinically grounded request that Novak's peer-reviewed paper supports. The request is not for more of the same monitoring. It is for the measurement that would actually see the problem.
Transcranial Doppler is the tool that provides this measurement — non-invasive, available in specialized autonomic laboratories, and validated as a standard component of comprehensive autonomic evaluation by the Norcliffe-Kaufmann 2017 standards paper. Combining TCD with capnography during tilt reveals both cerebral blood flow velocity and CO₂ dynamics simultaneously, providing the measurement basis for diagnosing OCHOS when the peripheral vital signs produce a normal result.
Orthostatic intolerance is a brain perfusion problem. OCHOS is the specific diagnostic category for the version of that problem in which brain perfusion fails while every standard cardiovascular metric holds steady. It is the most extreme demonstration of the gap between what standard tilt testing measures and what causes orthostatic intolerance symptoms — a gap that can only be closed by measuring what is actually failing. OCHOS gives that gap a name, a mechanism, and a measurement pathway. What it does not yet have is routine clinical recognition, which is the distance between 2016 and the present that patients with the condition are still navigating.